{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000506","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.151264+00:00","generated_at":"2026-05-24T06:12:42.097998+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sanara MedTech Q4 net revenue up 49% to $26.3M; net loss widens to $1.7M","bullets":["Q4 net revenue $26.3M (+49% YoY); full year $86.7M (+33% YoY).","Q4 net loss $1.7M vs $0.3M loss prior year; full year net loss $9.9M vs $4.4M.","Adjusted EBITDA Q4 $0.9M (vs $0.4M); full year $2.7M (vs $0.1M).","Sanara Surgical Q4 net income $0.9M; Tissue Health Plus segment loss $2.6M on platform buildout.","Exclusive license & distribution deal with BMI for OsStic bone void filler; term loan amended for additional borrowings."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000506","json":"https://secwatch.observer/filing/0001641172-25-000506.json","markdown":"https://secwatch.observer/filing/0001641172-25-000506.md","text":"https://secwatch.observer/filing/0001641172-25-000506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000164117225000506/0001641172-25-000506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000164117225000506/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:12:42.097998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}